The USFDA had issued an Emergency Use Authorization (EUA) to Gilead
Sciences Inc for emergency use of remdesivir for the treatment of
COVID-19 patients.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-launches-generic-remdesivir-for-covid-19-patients/articleshow/76498277.cms
No comments:
Post a Comment